Silo Wellness to Launch a Bob Marley-Labeled Line of Psilocybin Mushrooms
The family of Bob Marley and Silo Wellness have teamed up for the first line of commercial psilocybin mushrooms.
Author: Jill Ettinger
Psychedelic Business News Spotlight: March 12, 2021
This week in psychedelic business news, Canada expands legal distribution for psychedelics, therapeutic DMT stroke treatment, and more.
Canada Expands Psychedelic Approvals for Numinus
Numinus Biosciences has received expanded regulatory approval in Canada for psychedelic use and distribution.
North America Is Poised to Take the Lead In Emerging Psychedelic Drugs Market
The psychedelic drugs market is finding a strong base in North America, according to new data. The U.S. and Canada in particular are supporting its expansion.
Defiance Just Launched the World’s Second Psychedelics-Focused ETF
Defiance has launched the world’s second psychedelics-focused ETF as investing in psychedelic therapy and treatment accelerates.
Psychedelic Business News Spotlight: March 5, 2021
This week in psychedelic business news: two companies enter the Canadian Stock Exchange, AI comes to psychedelic treatment, and psilocybin comes to Brazil.
Psychedelic Biotech Company Atai Life Sciences Valued At $2 Billion
Biotech company Atai Life Sciences has earned a $2 billion valuation for its work in developing psychedelic treatments for mental health issues.
Michael Pollan Explores More Psychedelics In New Book: This Is Your Mind on Plants
New York Times bestselling author Michael Pollan explores mescaline, opium, and caffeine in his forthcoming book “This Is Your Mind on Plants”.
Former UFC Fighter Ian McCall’s Reeducation on Psychedelics Comes With a Puppet Show
It’s been nearly 3 years since Ian McCall stopped UFC fighting. Now, he’s bringing psychedelics mainstream with the help of puppets.
Psychedelic Business News Spotlight: February 26, 2021
This week in psychedelic business news, Field Trip upsizes its bought deal, psilocybin truffles head to Brazil, another company goes public, and more.
End of content
End of content